R&D chief Dean Li says Merck outflanked rivals with its sac-TMT cancer program

Merck's head of R&D Dean Li believes he’s outfoxed his competition for the next generation of oncology drugs, jumping into a wide set of indications that could help it expand the potential of its antibody-drug ...

endpoints.news ·3h ago

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Health & Medicine

After 30 Years, FDA Approves First-Ever Drug For a Rare Neurological Disorder

No longer just managing symptoms. Don't miss a story, subscribe here.

3h ago ·sciencealert.com

Emergency stockpiles are a luxury that not everyone can afford | Letters

Keira Callaghan says being prepared should be a public health measure, not a privilege, and Chris Rotheram is experiencing prescription anxiety.

3h ago ·theguardian.com

Zamfara Hails MSF Over Support Against Diphtheria Outbreak

The Zamfara State Government has commended Médecins Sans Frontières (MSF) for supporting efforts to contain the diphtheria outbreak in the state.

4h ago ·dailytrust.com

Healthy diet may lower heart disease risk after cancer

Eating a healthy diet is associated with a reduced risk of heart disease and death among cancer survivors, according to a study published today in JACC: Advances.

3h ago ·medicalxpress.com

Saudi program completes separation of Tanzanian conjoined twins after 15-hour surgery

The Saudi Conjoined Twins Program has successfully separated Tanzanian twins Laetines and Lovens, aged 2 years and 2 months, in its 75th case.

3h ago ·english.ajel.sa

Asutifi North MP provides free surgery for 130 people with hernia, other conditions

The Member of Parliament for Asutifi North in the Ahafo Region, Ebenezer Kwaku Addo, has sponsored free surgical procedures for 130 constituents suffering from hernia and three other medical…

3h ago ·adomonline.com